Pfizer could sell some assets, convert others into new companies amid broader refocus

Drug maker Pfizer Inc. could part with or distance itself from some of its research programs as it rethinks its approach to early development research in rare diseases and cancer treatments, the company said Thursday. The move by Pfizer PFE, would mark a considerable shift for a company trying to…#pfizerinc #bofa #marketwatch #pfizerpfe #pfizer #durham #barrons #rsv #boulder #colo
Source: Reuters: Health - Category: Consumer Health News Source Type: news